Occupational Therapists in North Kansas City, MO Accepting Medicare

7 Occupational Therapists found. Showing 1 - 7

Janet Morgan Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2700 Clay Edwards Dr Ste 150, North Kansas City, MO 64116 Phone: 816-421-7246

Mrs. Sonja Durece Vanhorn, OTR/L, CHT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1931 Burlington St, North Kansas City, MO 64116 Phone: 816-241-2131

Kathleen Faythe Smith, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1931 Burlington St, North Kansas City, MO 64116 Phone: 816-241-2131    Fax: 816-241-0551

Mitchell Roy Loiselle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2790 Clay Edwards Dr, North Kansas City, MO 64116 Phone: 816-691-1795

Nicole Bernard, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1950 Diamond Pkwy Ste 202, North Kansas City, MO 64116 Phone: 816-321-0311

Kristine Marie Timmermeyer Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Clay Edwards Dr, North Kansas City, MO 64116 Phone: 816-346-7400    Fax: 816-346-7404

Rebecca A Cavender, MOTR/L, CHT, CLT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2800 Clay Edwards Dr, North Kansas City, MO 64116 Phone: 816-691-1795    Fax: 816-346-7795

News Archive

Researchers find whether natural food has potential for preventing breast cancer in women

Women who have a higher-than-average risk of developing breast cancer may be concerned about taking cancer prevention drugs because of some of the associated side effects. Researchers at the University of Chicago Medicine are conducting a study to find out whether flaxseed, a natural food, has the potential to be a safe and effective alternative for preventing breast cancer in women.

BG Medicine receives US patent for galectin-3 testing to detect heart failure

BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.

JAMIA highlights several perspectives, five research articles on translational bioinformatics

With the summer edition of JAMIA-currently online at www.JAMIA.org-AMIA's peer-reviewed journal on informatics in biomedicine and health opens the door to translational science, highlighting several perspectives and five research articles on translational bioinformatics (TBI), and suggesting that future publications in greater volume will help keep JAMIA readers abreast of new developments and applications of translational bioinformatics, just as more hospital and academic health centers are embracing molecular measurements for diagnosis and planning therapies.

FDA, docs, consumers scrutinizing medical apps

Consumers are increasingly relying on mobile applications to monitor their own health as some question whether the FDA can evaluate the apps fast enough.

Read more Medical News

› Verified 4 days ago